EX-10.5(A) 4 aimt-ex105a_713.htm EX-10.5(A)Strategic Collaboration Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 Jurisdiction[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
STRATEGIC COLLABORATION AGREEMENT between NESTEC LTD. and AIMMUNE THERAPEUTICS, INC.Strategic Collaboration Agreement • March 15th, 2017 • Aimmune Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 15th, 2017 Company Industry JurisdictionThis STRATEGIC COLLABORATION AGREEMENT (this “Agreement”) is made as of November 3, 2016, by and between NESTEC LTD., a limited company organized and existing under the laws of Switzerland, having an office located at Avenue Nestlé 55, 1800 Vevey, Switzerland (“NHSc”), and Aimmune Therapeutics, Inc., a corporation incorporated and existing under the laws of the State of Delaware, having an office located at 8000 Marina Boulevard, Suite 300, Brisbane, CA 94005, USA (“Aimmune”). NHSc and Aimmune are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.